Lysosomal pathway involved in antigen presentation

The "Lysosomal activity/antigen presentation pathway via hydroxychloroquine" is not a single molecular target but rather refers to the cellular processes involving lysosomes that are critical for antigen processing and immune function. Hydroxychloroquine acts primarily by accumulating within acidic organelles such as lysosomes and endosomes. This raises their internal pH, which inhibits the function of acid-dependent enzymes responsible for protein degradation. As a result, antigen-presenting cells become less efficient at breaking down proteins into peptides suitable for loading onto major histocompatibility complex (MHC) class II molecules, thereby reducing T-cell activation against self-antigens—a key mechanism underlying its immunomodulatory effects in autoimmune diseases like lupus and rheumatoid arthritis[1][2][4][5]. Additionally, hydroxychloroquine blocks the fusion between autophagosomes and lysosomes—an essential step in cellular waste recycling known as autophagy—which can impact cell survival pathways relevant to cancer therapy as well as neurodegeneration[3]. The drug also affects other immune functions such as cytokine release through Toll-like receptor inhibition. Because this entry describes a pathway/process rather than an individual therapeutic target like a receptor or enzyme—and because it combines multiple concepts ("lysosomal activity," "antigen presentation," "hydroxychloroquine")—it is considered an incorrect format for canonical drug target nomenclature. If you need structured information on specific molecular targets modulated by hydroxychloroquine within this pathway—such as "Major histocompatibility complex class II" or "Toll-like receptor 7"—please specify further.

Other names

Lysosomal activityAntigen presentation pathwayEndolysosomal pathwayAutophagy-lysosome pathway

Increases lysosomal pH, inhibiting acidic hydrolase activity and proteolysis; Blocks fusion of autophagosomes with lysosomes, inhibiting autophagic flux; Impairs antigen processing by antigen-presenting cells by preventing peptide loading onto MHC class II molecules.